showed that in pancreatic cancer, tumor cells were able to reprogram M1-like macrophages metabolically and functionally through a GARP-dependent and via a DNA methylation-mediated mechanism to M2 macrophages with a pro-tumorigenic phenotype (11). Here, LRRC32 is linked to neoplasm.